Is tirzepatide (Mounjaro) metabolized primarily by the liver or the kidneys?

Tirzepatide Metabolism

Tirzepatide is metabolized primarily through proteolytic cleavage and does not undergo significant hepatic cytochrome P450 metabolism or renal elimination as an intact drug. 1

Primary Metabolic Pathway

• Tirzepatide is metabolized via proteolytic degradation rather than through traditional hepatic enzyme systems like CYP450, distinguishing it from many other medications that require dose adjustment in liver disease 1
• The drug undergoes breakdown through peptidase enzymes distributed throughout the body, not concentrated in a single organ 1

Renal Considerations

• No dose adjustment is necessary for mild to moderate renal impairment, indicating that kidney function does not significantly affect tirzepatide clearance 1
• Caution is advised when initiating or escalating doses in patients with renal impairment due to potential acute kidney injury risk from dehydration secondary to gastrointestinal side effects, not from direct renal metabolism 1
• The elimination half-life is 5 days, allowing for once-weekly dosing 1

Hepatic Considerations

• Tirzepatide does not require hepatic dose adjustment because it is not metabolized through liver enzyme pathways 1
• Unlike medications such as apixaban (73% non-renal clearance with hepatic metabolism) 2 or rivaroxaban (hepatic elimination 18%) 2, tirzepatide's proteolytic metabolism occurs systemically rather than being concentrated in the liver 1

Clinical Implications

• The lack of significant hepatic or renal metabolism means tirzepatide has minimal drug-drug interactions compared to medications metabolized by CYP450 enzymes 1
• Tirzepatide delays gastric emptying, which can affect absorption of oral medications with narrow therapeutic indices (e.g., warfarin), but this is a pharmacodynamic effect rather than a metabolic interaction 1
• Patients using oral hormonal contraceptives should add a non-oral contraceptive method for 4 weeks after initiation and each dose escalation due to delayed gastric emptying affecting oral medication absorption, not metabolic interference 1